Telomere dysfunction and chromothripsis

International Journal of Cancer

Volumn 138, Issue 12, 2016, Pages 2905-2914

  Ernst, Aurélie ^a   Jones, David T W ^a   Maass, Kendra K ^a   Rode, Agata ^a   Deeg, Katharina I ^a   Jebaraj, Billy Michael Chelliah ^b   Korshunov, Andrey ^a   Hovestadt, Volker ^a   Tainsky, Michael A ^c   Pajtler, Kristian W ^a   Bender, Sebastian ^a   Brabetz, Sebastian ^a   Gröbner, Susanne ^a   Kool, Marcel ^a   Devens, Frauke ^a   Edelmann, Jennifer ^b   Zhang, Cindy ^d   Castelo Branco, Pedro ^d   Tabori, Uri ^d   Malkin, David ^d   Rippe, Karsten ^a   Stilgenbauer, Stephan ^b   Pfister, Stefan M ^a   Zapatka, Marc ^a   Lichter, Peter ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

chromothripsis; genome instability; genomic catastrophe; telomere

Indexed keywords

ADULT; ARTICLE; BREAKAGE FUSION BRIDGE; CHROMOSOME SHATTERING; CHROMOSOME STRUCTURE; CHROMOTHRIPSIS; CONTROLLED STUDY; DNA FRAGMENTATION; GENE SEQUENCE; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; LONGITUDINAL STUDY; PRIORITY JOURNAL; TELOMERE ATTRITION; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; TUMOR RECURRENCE; CASE CONTROL STUDY; CEREBELLUM TUMOR; CHROMOSOME DISORDER; ENZYMOLOGY; EPENDYMOMA; GENE EXPRESSION; GENETICS; MEDULLOBLASTOMA; METABOLISM;

TELOMERASE; TERT PROTEIN, HUMAN;

CASE-CONTROL STUDIES; CEREBELLAR NEOPLASMS; CHROMOSOME DISORDERS; EPENDYMOMA; GENE EXPRESSION; GENOMIC INSTABILITY; HUMANS; MEDULLOBLASTOMA; TELOMERASE; TELOMERE HOMEOSTASIS;

EID: 84959264048     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30033     Document Type: Article

References (47)

1. Stephens PJ, Greenman CD, Fu B, et al., Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011; 144: 27-40.
2. Rausch T, Jones DT, Zapatka M, et al., Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 2012; 148: 59-71.
3. Korbel JO, Campbell PJ., Criteria for inference of chromothripsis in cancer genomes. Cell 2013; 152: 1226-36.
4. Rode A, Maass KK, Willmund KV, Lichter P, Ernst A,. Chromothripsis in cancer cells, an update. Int J Cancer 2015. doi: 10.1002/ijc.29888. [Epub ahead of print] Review.
5. Molenaar JJ, Koster J, Zwijnenburg DA, et al., Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 2012; 483: 589-93.
6. Zhang CZ, Spektor A, Cornils H, et al., Chromothripsis from DNA damage in micronuclei. Nature 2015; 522: 179-84.
7. Maher CA, Wilson RK., Chromothripsis and human disease: Piecing together the shattering process. Cell 2012; 148: 29-32.
8. Li Y, Schwab C, Ryan SL, et al., Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia. Nature 2014; 508: 98-102.
9. Falandry C, Bonnefoy M, Freyer G, et al., Biology of cancer and aging: A complex association with cellular senescence. J Clin Oncol 2014; 32: 2604-10.
10. Wong JM, Collins K., Telomere maintenance and disease. Lancet 2003; 362: 983-8.
11. Sharpless NE, Sherr CJ., Forging a signature of in vivo senescence. Nat Rev Cancer 2015; 15: 397-408.
12. Marzec P, Armenise C, Perot G, et al., Nuclear-receptor-mediated telomere insertion leads to genome instability in ALT cancers. Cell 2015; 160: 913-27.
13. McClintock B., The stability of broken ends of chromosomes in zea mays. Genetics 1941; 26: 234-82.
14. Henson JD, Neumann AA, Yeager TR, et al., Alternative lengthening of telomeres in mammalian cells. Oncogene 2002; 21: 598-610.
15. Zhang C, Chen X, Li L, Zhou Y, Wang C, Hou S,. The association between telomere length and cancer prognosis: Evidence from a meta-analysis. PLOS One 2015. doi: 10.1371/journal.pone.0133174. eCollection 2015.
16. Hakin-Smith V, Jellinek DA, Levy D, et al., Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 2003; 361: 836-8.
17. LHaD R., Fast and accurate short read alignment with Burrows-Wheeler Transform. Bioinformatics 2009; 25: 1754-60.
18. Klambauer GSK, Mayr A, Mitterecker A, et al., cn.MOPS: Mixture of poissons for discovering copy number variations in next genereation sequencing data with a low false discovery rate. Nucleic Acids Res 2012; 40: e69. doi: 10.1093/nar/gks003. Epub 2012 Feb 1.
19. Edelmann J, Holzmann K, Miller F, et al., High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 2012; 120: 4783-94.
20. Pajtler KW, Witt H, Sill M, et al., Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 2015; 27: 728-43.
21. Jones DT, Jager N, Kool M, et al., Dissecting the genomic complexity underlying medulloblastoma. Nature 2012; 488: 100-5.
22. O'Callaghan N, Dhillon V, Thomas P, et al., A quantitative real-time PCR method for absolute telomere length. BioTechniques 2008; 44: 807-9.
23. Jebaraj BM, Kienle D, Lechel A, et al., Telomere length in mantle cell lymphoma. Blood 2013; 121: 1184-7.
24. Daniel E, Ho KI, Gary K, et al,. Matchlt: Nonparametric preprocessing for parametric causal inference. J Stat Software 2011; 42: 1-28.
25. Lichter P, Tang CJ, Call K, et al., High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 1990; 247: 64-9.
26. Schwartzentruber J, Korshunov A, Liu XY, et al., Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012; 482: 226-31.
27. Tabori U, Wong V, Ma J, et al., Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma. Br J Cancer 2008; 99: 1129-35.
28. Henson JD, Cao Y, Huschtscha LI, et al., DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity. Nat Bio 2009; 27: 1181-5.
29. Bischoff FZ, Yim SO, Pathak S, et al., Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: Aneuploidy and immortalization. Cancer Res 1990; 50: 7979-84.
30. Gollahon LS, Kraus E, Wu TA, et al., Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts. Oncogene 1998; 17: 709-17.
31. Ohgaki H, Eibl RH, Schwab M, et al., Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog 1993; 8: 74-80.
32. Tzaridis TD., Novel P53-targeted therapeutic approaches to the treatment of high-risk ependymomas. Inaugural Dissertation for the Acquisition of the Doctoral Degree at the Medical Faculty of Heidelberg, 2014.
33. Barszczyk M, Buczkowicz P, Castelo-Branco P, et al., Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells. Acta Neuropathol 2014; 128: 863-77.
34. Modena P, Buttarelli FR, Miceli R, et al., Predictors of outcome in an AIEOP series of childhood ependymomas: A multifactorial analysis. Neuro-Oncol 2012; 14: 1346-56.
35. Heaphy CM, Subhawong AP, Hong SM, et al., Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol 2011; 179: 1608-15.
36. Remke M, Ramaswamy V, Peacock J, et al., TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol 2013; 126: 917-29.
37. Tabori U, Nanda S, Druker H, et al., Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Cancer Res 2007; 67: 1415-8.
38. Nones K, Waddell N, Wayte N, et al., Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nat Commun 2014; 5: 5224
39. Cesare AJ, Reddel RR., Alternative lengthening of telomeres: Models, mechanisms and implications. Nat Rev Genet 2010; 11: 319-30.
40. Ohyashiki JH, Sashida G, Tauchi T, et al., Telomeres and telomerase in hematologic neoplasia. Oncogene 2002; 21: 680-7.
41. Calado RT, Regal JA, Hills M, et al., Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci USA 2009; 106: 1187-92.
42. Bassaganyas L, Bea S, Escaramis G, et al., Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis. Leukemia 2013; 27: 2376-9.
43. Pampalona J, Frias C, Genesca A, et al., Progressive telomere dysfunction causes cytokinesis failure and leads to the accumulation of polyploid cells. PLoS Genet 2012; 8: e1002679
44. Mardin BR, Drainas AP, Waszak SM, et al., A cell-based model system links chromothripsis with hyperploidy. Mol Syst Biol 2015; 11: 828
45. Gisselsson D, Jonson T, Petersen A, et al., Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci USA 2001; 98: 12683-8.
46. Garsed DW, Marshall OJ, Corbin VD, et al., The architecture and evolution of cancer neochromosomes. Cancer Cell 2014; 26: 653-67.
47. Maciejowski J, Li Y, Bosco N, et al., Chromothripsis and kataegis induced by telomere crisis. Cell 2015; 163: 1641-54.